REFERENCES
Ambrose M, Bowden S, Whelan G (2001).
thiamine Treatment and Working memory Function of
Alcohol-Dependent People: Preliminary Findings.
Alcohol Clin Exp Res; 25(1):112-116.
Andree M (1980).
Sudden death following naloxone administration.
Anesth Analg 59: 782-784.
Anonymous (1989).
AA Membership Survey. New York, NY: Alcoholics Anonymous
World Service, Inc.
Anonymous (1996).
AA Membership Survey. New York, NY: Alocoholics Anonymous
World Service, Inc.
Anton et al (1981).
Multiple family therapy and naltrexone in the treatment of opiate
dependence. Drug and Alcohol Dependence, 8, 157-168.
Baker, A., & Reichler, R.
Motivational Interviewing. Clinical Skills Series: effective approaches
to alcohol and other drug problems. Visual Education. Suffolk.
Ball JC & Ross A (1991).
The effectiveness of methadone maintenance treatment: Patients,
programs, services and outcomes. New York: Springer-Verlag.
Beaini A, Johnson T, Langstaff P, Carr M, Crossfield A andSweeney R (2000).
A compressed opiate detoxification regime with naltrexone
maintenance: patient tolerance, risk assessment and abstinence rates.
Addiction Biology 5: 451-462.
Beck A, Steer R (1994).
Beck Hopelessness Scale Manual. San Antonio,TX, Harcourt Brace.
Beck A, Brown G, Berchick R et al (1990).
Relationship between hopelessness and ultimate suicide: a replication
with psychiatric patients. Am J Psychiatry 147:190-195.
Bell J,Young M, Materman S, Morris A, Mattick R, Bammer G (1999);.
A Pilot Study of Naltrexone-Accelerated Detoxification in Opioid
Dependence.MJA; 171:26-30.
Bellini C, Boccuni M, D’Egidio P (1982).
Naloxone anisocuria: a non-invasive, inexpensive test for
opiate addiction. International Journal of Clinical Pharmacology
Research; 2:55-60.
Beresford TP, Blow FC, Hill E, Singer K & Lucey MR (1990).
Comparison of CAGE questionnaire and computer-assisted laboratory
profiles in screening for covert alcoholism. Lancet 336: 482-485.
Bernard O (1998).
Mother-to-infant transmission of hepatitis C.
Acta Gastro-Enterologica Belgica; 61:192-194.
Bock HL, Loscher T, Scheiermann N, Baumgarten R, Wiese M, Dutz W, Sanger R, Clemens R (1995).
Accelerated Schedule for Hepatitis B Immunisation.
J Travel Med 1995; 2:213-217.
British Association for Counselling (1988).
Code of Ethics and Practice for Counselling Skills. BAC. Rugby.
British Association for Counselling (1996).
Code of Ethics and Practice for Counsellors. BAC. Rugby.
British Association for Counselling (1996).
Code of Ethics and Practice for Supervisors of Counsellors.
BAC. Rugby.
Buntwal N, Bearn J, Gossop M, Strang J (2000).
Naltrexone and lofexidine combination treatment compared with
conventional lofexidine treatment for in-patient opiate detoxification.
Drug and Alcohol Dependence 59; 183-188.
Callaway CW & Clark RF (1994).
Hyperthermia in psychostimulant overdose. Annals of Emergency
Medicine 24: 68-75.
Caplehorn JRM & Bell J (1991).
Methadone dosage and retention of patients in maintenance
treatment. Medical Journal of Australia, 154, 195-199.
Carroll, (1996.).
CBT and Inter-Personal Therapy.A Cognitive Behavioural
Approach:Therapy Manuals for Drug Addiction. National Institute
on Drug Abuse.
Carroll K (1997).
Integrating psychotherpay and pharmacotherpay to improve drug
abuse outcomes. Addictive Behaviours; 22(2):223-245.
Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA (1985).
Cocaine use in pregnancy. New England Journal of Medicine
313: 666-669.
Chasnoff IJ, Bussey ME, Savich R & Stack CM (1986).
Perinatal cerebral infarction and maternal cocaine use. Journal of
Paediatrics 108: 456-459.
Childress et al (1993).
Cue reactivity and cue reactivity interventions in drug dependence. In
L. S. Onken, J.D. Blaine, & J.J. Boren (Eds.), Behaviour treatments for
drug abuse and dependence (pp. 73-95). NIDA Research Monograph
Series No. 137. Rockville, MD: National Institute on Drug Abuse.
Christo G & Graney C (1995).
Drug users’ spiritual beliefs, locus of control and the disease concept
in relation to Narcotics Anonymous attendance and six-month
outcomes. Drug and Alcohol Dependence 38: 51-56.
Connor E, Sperling R, Gelber R, Kiselev P, Scott G,
O’Sullivan M (1994).
Reduction of maternal-infant transmission of human
immunodeficiency virus type 1 with zidovudine treatment.
N Engl J Med; 331:1173-1180.
Coulter H (1980).
Homoeopathic Science and Modern Medicine
Creighton F, Ghodse H (1989).
Naloxone applied to conjunctiva as a test for physical opiate
dependence. Lancet; 333: 748-750.
Cyr MG & Wartman SA (1988).
The effectiveness of routine screening questions in the detection of
alcoholism. Journal of the American Medical Society 259: 51-54.
D’Ambra C (1998).
Should rapid detoxification be performed by nonanesthesiologists?
Physicians Weekly, 15(4), 102-103.
Dashe J, Jackson G, Olscher D, Zane E,Wendel G (1998).
Opioid detoxification in pregnancy. Obstetrics and gynaecology;
92 (5):854-858.
Di Bisceglie A (1998).
Hepatitis C. Lancet, 1998; 351: 351-355.
Dolan M (1998).
The Hepatitis C Handbook.
Drug Misuse and Dependence – Guidelines on
Clinical Management (1999).
DoH.HMSO.
Drugs and Therapuetics Bulletin, vol 38, no 10, October 2000 Dunn C, Deroo L, Rivara F (2001).
The use of brief interventions adapted from motivational
interviewing across behavioural domains: a systematic review.
Addiction; 96: 1725-1742.
Eap C, Deglon J, Baumann P (1999).
Pharmacokinetics and pharmacogenetics of methadone: Clinical
relevance. Heroin Addict Relat Clin Probl,; 1:19-34.
Effective Health Care Team.
Brief Interventions and Alcohol Use:Are Brief Interventions Effective
in Reducing Harm Associated with Alcohol Consumption? Effective
Healthcare Bulletin, No 7 (London, Department of Health).
Effectiveness Review, 1996.
The Task Force to Review Services for Drug Misusers: Report
of an Independent Survey of Drug Treatment Services in England.
DoH 1996.
European Collaborative Study (1996).
Vertical Transmission of HIV-1: maternal immune status and obstetric
factrs.AIDS; 10:1575-1681.
Finnegan LP (1990).
‘Neonatal abstinence’, in Nelson NM (ed), Current Therapy in
Neonatal-Perinatal Medicine;Vol 2,Toronto: BC Dekker.
Finnegan LP & Ehrlich SM (1990).
Maternal drug abuse during pregnancy: Evaluation and
pharmacotherapy for neonatal abstinence. Modern Methods
of Pharmacologic Testing in the Evaluation of Drugs of Abuse
6:255-263.
Finnegan LP & Kaltenbach K (1992).
Neonatal abstinence syndrome. In RA Hoekelman, SB Friedman,
N Nelson & HM Seidel (eds.) Primary Paediatric Care (2nd Edition).
St.Louis, MO: CV Mosby, 1367-1378.
Fiore MC, Bailey WC, Cohen SC et al (1996). R1 Smoking cessation. Clinical practice guideline no. 18. Rockville, Md.: Agency for Health Care Policy and Research, April. (AHCPR publication no. 96-0692)
Fleming M et al (1997).
Brief Physician Advice for Problem Alcohol Drinkers. A Randomised
Controlled Trial in Community-based Primary Care Practices. JAMA.
Apr 2; 277: 1039-45.
Fleming M et al. (1999).
Brief Physician Advice for Alcohol Problems in Older Adults.A
Randomised Community-based Trial. J Fam Pract. May; 48: 378-84.
Garfein RS,Vlahov D, Galai N, Doherty MC & Nelson KE (1996).
Viral infections in short-temr injection drug users:The prevalence
of hepatitis C, hepatitis B, human immunodeficiency, and human Tlymphotropic
viruses.American Journal of Public Health 86: 655-61.
Gerra G, Zaimovic A, Rustichelli P, Fontanesi B, Zambelli U, Timpano M, Bocchi C, Delsignore R (2000).
Rapid opiate detoxification in outpatient treatment. Relationship
with naltrexone compliance. Journal of Substance Abuse Treatment
18:185-191.
Ghodse H, Bewley T, Kearney M (1986).
Mydriatic response to topical naloxone in opiate abusers.
British Journal of Psychiatry, 148: 44-46.
Ghodse H, Greaves J, Lynch D (1999).
Evaluation of the opioid addiction test in an out-patient drug
dependency unit. British Journal of Psychiatry; 175: 158-162.
Gossop, M. et al (1999).
Treatment retention and one year outcomes for residential
programmes in England. Drug and Alcohol Dependence 57: 89-98.
Gossop M, Strang J (2000).
Price, cost and value of opiate detoxification treatments. Reanalysis of
data from two randomised trials. Br J Psychiatry Sep; 177:262-6.
Gowing L, Ali R, White J (2000).
Opioid antagonists and adrenergic agonists for the management of
opioid withdrawal (Cochrane Review) In:The Cochrane Library,
Issue 3, 2000. Oxford: Update Software.
Gowing L, Ali R, White J (2001).
Opioid antagonists under sedation or aneathesia for opioid
withdrawal. Cochrane Database Syst Rev (1):CD002022.
Gronholm M, Lillsunde P (2001).
A comparison between on-site immunoassay drug-testing devices and
laboratory results. Forensic Science International, 121: 37-46.
Gunne LM & Gronbladh L (1981).
The Swedish methadone maintenance programme: A controlled study.
Drug and Alcohol Dependence, 7, 249-256.
Harris, H. (2001).
Concrete Counselling: ignoring outcomes. Druglink. Vol 16:1
(pp10-13).
Heather et al (1997).
Matching Alcoholism Treatments to Client Heterogeneity: Project
Match Post Treatment Drinking Outcomes. Journal of Studies on
Alcohol. 58 (pp7-29)
Higgins S, Budney A.
Treatment of cocaine dependence through principles of behaviour
analysis and behavioural pharmacology. In Onken L, Blaine J,
Boren J (eds.): Behavioural Treatments for Drug and Alcohol
Dependence. NIDA Research Monograph Series No. 137.
Rockville,MD, NIDA, 1993, pp97-121.
Hoffman NG & Miller MS (1992).
Treatment outcomes for abstinence-based programmes.
Psychiatric Annals 22: 402-408.
Hunt C, Carson K, Sharara A (1997).
Hepatitis C in pregnancy. Obstet Gynecol; 89: 883-890.
Hurlbut KM (1991).
Drug-induced psychoses. Emergency Medicine Clinics of North
America 9(1): 31-52.
Hyman (ed.).
Manual of Psychiatric Emergencies. Boston, MA: Little,
Brown & Co., 217-227.
Jaffe J(1995).
Pharmacological Treatment of Opioid Dependence: Current
Techiques and New Findings. Psychiatric Annals; 25: 369-375.
Johnson RE, Jones HE, Jasinski DR, Svikis DS, Haug NA, Jansson LM, Kissin WB, Alpan G, Lantz ME, Cone EJ,
Wilkins DG, Golden AS, Hugging GR, Lester BM. (2001).
Buprenorphine treatment of pregnant opioid--dependent women:
maternal and neonatal outcomes. Drug Alcohol Depend;
63(1):97-103.
Jorenby DE et al (1999).
A controlled trial of sustained-release buproprion, a nicotine patch,
or both for smoking cessation. New England Jounral of Medicine,
vol 340:685-691,.
Kahan M et al (1995).
Effectiveness of Physician-based Interventions with Problem Drinkers:
a Review. Can Med Assoc J. Mar 15; 152: 851-9.
Kaltenbach K, Finnegan L (1997).
Children of maternal substance misusers. Current Opinion in
Psychiatry; 10: 220-224.
Kandall SR (1993).
Improving Treatment for Drug-Exposed Infants (Treatment
Improvement Protocol Series). Rockville MD: Center for
Substance Abuse Treatment, 14-15.
Kirchmayer U, Davoli M,Verster A (2000).
Naltrexone maintenance treatment for opioid dependence.
(Cochrane Review) In:The Cochrane Library, Issue 3.
Kleber H (1985). Naltrexone. J Substance Abuse Treatment;
2:117-122.
Kramer LD, Locke GE, Ogunyemi A & Nelson L (1990).
Neonatal cocaine-related seizures. Journal of Child
Neurology 5: 60-64.
Leino A, Saarimies J, Gronholm M, Lillsunde P (2001).
Comparison of eight commercial on-site screening devices for
drugs-of-abuse testing. Scand J Clin Lab Invest; 61: 325-332.
Liese B, Beck A (1996).
Back to Basics: Fundamental Cognitive Therapy Skills for Keeping
Drug-dependent Individuals in Treatment. Book.
Ling W,Wesson DR, Charuvastra C & Klett J (1996).
A controlled trial comparing buprenorphine and methadone
maintenance in opioid dependence.Archives of General Psychiatry,
53, 401-407.
Litovitz T (1987).
Fatal benzodiazepine toxicity.American Journal of Emergency
Medicine 5: 472-473.
Longabaugh R et al (1993).
The effect of social support on treatment outcome. Journal of Studies
on Alcohol, 54, 465-478.
Mandelbrot L (1997).
Timing of in utero HIV infection: implications for prenatal diagnosis
and management of pregnancy.AIDS Patient Care and STDs;
11: 429-435.
Mandelbrot L (1998).
Vertical Transmission of Viral Infections. Current Opinion in
Obstetrics and Gynecology; 10: 123-128.
Marsden J, Gossop M, Stewart D, Best D, Farrell M,
Lehmann P, Edwards C, Strang J (1998).
The Maudsley Addiction Profile (MAP): a brief instrument for
assessing treatment outcome. Addiction; 93(12):1857-67.
Mattick RP & Darke S (1995).
Drug replacement treatments: is amphetamine substitution a horse of
a different colour? Drug and Alcohol Review; 14: 398 – 394.
Mayaux M,Teglas J, Madelbrot L, Berrebi A, Gallais H,
Matheron S (1997).
Acceptability and impact of zidovudine prevention on mother-tochild
HIV-1 transmission in France. J Paediatr; 131:857-862.
Mayo-Smith M (1997).
Pharmacological Management of Alcohol Withdrawal –
A Meta-Analysis and Evidence-Based Practice Guideline.
JAMA; 278(2): 144-151.
McCarthy J, Posey B (2000).
Methadone levels in Human Milk. J Hum Lact 16(2):115-120.
Strupp H, Schacht T, Henry W, Binder J, Jack M (1992).
A Case of Premature Termination. Psychotherapy 29: 191-205,.
McLellan et al (1993).
The effects of psychosocial services in substance abuse treatment.
JAMA, 269, 1953-1959.
McClellan A, Alterman A,Woody G, Metzger D, McKay J, O’Brien C (1994).
Evaluating the Effectiveness of Substance Misuse Treatment.A Report
prepared for the Task Force.
McCrady B & Epstein E.
Theoretical bases of family approaches to substance abuse treatment.
In Rogers F, Keller D, Morgenstern J (eds.):Treating Substance
Abusers:Theory and Technique. New York, Guilford, 1996,
pp 117-142.
McLachlan-Troup N,Taylor G,Trathen B (2001).
Diamorphine treatment for opiate dependence: putative markers
of concomitant heroin misuse. Addiction Biology; 6:223-231.
Michielsen P,Van Damme P (1999).
Viral hepatitis and Pregnancy. Acta Gastro-Enterologica Belgica,
62:21-29.
Miller W (1983).
Motivational interviewing with problem drinkers. Behavioural
Psychotherapy; 11:147-172.
Miller W (1985).
Motivation for Treatment:A Review with Special Emphasis on
Alcoholism. Psychol Bull 98: 84-107.
Miller W, Rollnick S (1991).
Motivational Interviewing: preparing people to change addictive
behaviour. New York, Guilford Press.
Miller WR et al (1993).
Enhancing Motivation for Change in Problem Drinking; a Controlled
Comparison of Therapist Styles. J Consult Clin Psychol.; 61:455-461.
Miller W & Tonigan JS (1996).
Assessing a drinker’s motivations for change:The Stages of Change
Readiness and Treatment Eagerness Scale (SOCRATES). Psychology
of Addictive Behaviours 10(2): 81-89.
Miller,W.R., & Sanchez (1999).
Common Elements of Brief Intervention (Frames). Alcohol Alert. 43.
Minkoff H, Augenbraun M.
Antiretroviral therapy for pregnant women.Am J Obstet Gynecol;
176:478-489.
Moos R, Nichol A, Moos B (2002).
Risk factors for symptom exacerbation among treated patients with
substance misuse disorders, Addiction 97(1): 75-86.
Nademanee K, Gorelick DA, Josephson MA et al (1989).
Myocardial ischaemia during cocaine withdrawal. Annals of Internal
Medicine 111: 876-880.
Newman R & Whitehill W (1979).
Double-blind comparison of methadone and placebo maintenance
treatments of narcotic addicts in Hong Kong. Lancet, 8, 485-488.
Newman C (1994).
Establishing and maintaining a Therapeutic Alliance With Substance
Abuse Patients:
NICE appraisal of combination therapy for hepatitis C.
www.nice.org.uk
Nilssen O (1991).
The Tromso Study: Identification of and a Controlled Intervention on
a Population of Early-Stage Risk Drinkers. Prev med. May-Jun; 20:
518-28.
Gossop M, Stewart D, Rolfe A, Marsden J (1999).
NTORS:Two year Outcomes. The National Treatment Outcome
Research Study. 4th Bulletin. Pub. DoH.
O’Connor P, Kosten T (1998).
Rapid and Ultrarapid Opioid Detoxification Techniques. JAMA,
279(3), 229-234.
Ohto H,Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C (1994).
Transmission of hepatitis C virus from mothers to infants.
N Engl J Med; 330:744-50.
Pearsall HR & Rosen MI (1992).
Inpatient treatment of cocaine addiction. In TR Kosten & HD Kleber
(eds.). Clinicians Guide to Cocaine Addiction:Theory, Research and
Treatment. New York, NY: Guilford Press, 314-334.
Perera KM,Tulley M, Jenner FA (1987).
The use of benzodiazepines among drug addicts. British Journal of
Addiction; 82: 511-515.
Prochaska JO & DiClemente CC (1992).
Stages of change in the modification of problem behaviours. Progress
in Behaviour Modification 28: 183-218.
Prochaska J, Norcross J, DiClemente C.
Changing for Good. New York:William Morrow & Co, 1994.
Project MATCH Research Group: Project MATCH (1993).
Rationale and methods for a multisite clinical trial matching
alcoholism patients to treatment. Alcohol Clin Exp Res 17:
1130-1145.
Ravi N, Maany I, Burke W, Dhopesh V,Woody G (1990).
Detoxification with phenobarbital of alprazolam-dependent
polysubstance abusers. J Subst Abuse Treat; 7(1): 55-8.
Regier et al (1990).
Comorbidity of mental disorders with alcohol and other drug use.
JAMA, 264, 2511-2518.
Reid M, Anderson P (1997).
Geriatric Substance Use Disorders. Alcohol and Other Substance
Abuse; 81(4):999-1016.
Robertson N (1988).
Getting Better Inside Alcoholics Anonymous. New York, NY:
Ballantine Books.
Russell M et al (1979).
Effect of General Practitioner’s Advice Against Smoking.
BMJ.; 2:231-235.
Saitz R, Mayo-Smith MF, Roberts MS, Redmond HA, Bernard DR, Calkins DR (1994).
Individualised treatment for Alcohol Withdrawal – A Randomised
Double-blind Controlled Trial. JAMA; 272(7): 519-523.
SCODA (1996).
Structured Dat Services ISBN 0948970 14 6
SCODA (1997).
Enhancing Drug Services (SSDASM3)
Smith D, Landry M (1990).
Benzodiazepine dependency discontinuation: focus on the chemical
dependency detoxification setting and benzodiazepine-polydrug
abuse. J Psychiatr Res; 24 Suppl 2:145-56.
Steinweg DL & Worth H (1993).
Alcoholism:The key to the CAGE.American Journal of Medicine
94:520-23
Sterling R, Gottheil E,Weinstein S, Shannon D (1994).
Psychiatric symptomatology in Crack Coaine Abusers. J Nerv Ment
Dis 182: 564-569.
Stitzer M, Bickel W, Bigelow G et al (1986).
Effect of methadone dose contingencies on urinalysis test results of
poly-drug –abusing methadone maintenance patients. Drug Alcohol
Depend 18: 341-348.
Strang J, Sheridan J (1997).
Prescribing amphetamines to drug misusers: data from the 1995
national survey of community pharmacies in England and Wales.
Addiction; 92: 833-838.
Sullivan JT, Swift RM, Lewis DC (1991).
Benzodiazepine Requirements During Alcohol Withdrawal
Syndrome: Clinical Implications of Using a Standardised Withdrawal
Scale. J Clin Psychopharmacol; 11: 291-295.
Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989).
Assessment of Alcohol Withdrawal:The Revised Clinical Institute
Withdrawal Assessment for Alcohol Scale (CIWA-Ar). British Journal
of Addiction; 84: 1353-1357.
Swett C, Noones J (1989).
Factors associated with premature termination from outpatient
treatment. Hosp Community Psych 40: 947-951.
Taft R (1983).
Pulmonary edema following naloxone administration in a patient
without heart disease. Anesthesiology, 59: 576-577.
Tenant F & Moll D (1995).
Seroprevalence of hepatitis A, B, C and D markers and liver function
abnormalities in intravenous heroin addicts. Journal of Addictive
Diseases 14: 35-49.
Tonigan JS,Toscova R & Miller WR (1996).
Meta-analysis of the literature on Alcoholics Anonymous: Sample and
study characteristics moderate findings. Journal of Studies on Alcohol
57: 65-72.
Weiss RD, Greenfield SF & Mirin SM (1994).
Intoxication and withdrawal sydromes. In SE
WHO Brief Intervention Study Group (1996).
A Cross-national Trial of Brief Interventions with Heavy Drinkers.
Am J Public Health.; 86: 948-955.
Wilk A et al (1997).
Meta-analysis of Randomised Controlled Trials Addressing
Brief Interventions in Heavy Alcohol Drinkers. J Gen Intern
med; 12: 274-283.
Wolff K, Rostami-Hodjegan A, Hay A, Raistrick D,Tucker G (2000).
Population-based pharmacokinetic approach for methadone
monitoring of opiate addicts: potential clinical utility. Addiction,
95(12):1771-1783.
Wolff K, Hay AW,Vail A, Harrison K, Raistrick D (1996)
Non-prescribed drug use during methadone treatment by clinic –
and community-based patients. Addiction; 91(11): 1699-704
Wong DK,Yim C, Naylor CD et al.
(1995). Interferon alpha treatment of Chronic hepatitis B:
Randomised trial in a predominantly homosexual male population.
Gastroenterology 108: 165-171.
Wurst F, Kempter C, Seidl S, Alt A (1999).
Ethyl Glucuronide – A Marker of Alcohol Consumption and
a Relapse Marker with Clinical and Forensic Implications.
Alcohol & Alcoholism; 34(1): 71-77.
The above information is copyright of Dr Bruce Trathen MBBS MRCPsych (2006). ISBN 0-9545164-0-0. The author grants permission for these guidelines to be downloaded, copied and distributed freely, but does not grant permission for their sale.
Medical Information
Why dryoutnow.com
Alcoholism Services
